title: Local recurrence and survival in soft-tissue sarcomas.
abstract: BACKGROUND
  There is a continuous interest in the literature concerning the management and survival after treatment of local recurrence in sarcomas because it is one of the most common types of recurrence.
  
  
  METHODS
  We retrospectively reviewed 93 patients treated for local recurrence from soft-tissue sarcoma.
  
  
  METHODS
  We evaluated prognostic parameters (grade, tumor size, location) and the effect of treatment on survival.
  
  
  RESULTS
  Resection of all the gross tumor at first visit to our Institute for local recurrence was accomplished in 88 patients (95%). Of the 59 patients with extremity tumors, six (10%) required an amputation. At a mean follow-up of 66 months, further local recurrence was noted in 27%. The estimated 5-year survival rate was 100% for patients with grade I tumors (n = 16), 77% for grade II (n = 31), and 45% for grade III tumors (n = 46) (p = 0.0002). This value was 78% for tumors < or = 5 cm and 57% for those > 5 cm (p = 0.03).
  
  
  CONCLUSIONS
  Local recurrence is resectable and limb preservation is possible in the majority of patients. The overall 5-year survival rate was 65%. Survival after treatment of local recurrence is determined mainly by the grade and secondarily by the size of the tumor as for primary sarcomas.
authors.affiliation: Millard Fillmore Hospitals, State University of New York, Buffalo 14209, USA.
authors.forename: C P
authors.initials: CP
authors.lastname: Karakousis
authors.forename: C
authors.initials: C
authors.lastname: Proimakis
authors.forename: U
authors.initials: U
authors.lastname: Rao
authors.forename: A F
authors.initials: AF
authors.lastname: Velez
authors.forename: D L
authors.initials: DL
authors.lastname: Driscoll
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality* / Q000473:pathology / Q000601:surgery; D011379:Prognosis; D012189:Retrospective Studies; D012509:Sarcoma / Q000401:mortality* / Q000473:pathology / Q000601:surgery; D012983:Soft Tissue Neoplasms / Q000401:mortality* / Q000473:pathology / Q000601:surgery; D015996:Survival Rate